Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer

被引:0
|
作者
Brennan, D. J. [1 ]
Ehlen, A. [2 ]
McGee, S. [1 ]
O'Connor, D. P. [1 ]
Jirstrom, K. [2 ,3 ]
机构
[1] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland
[2] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden
[3] Lund Univ, CREATE Hlth Ctr Translat Canc Res, Lund, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
21
引用
收藏
页码:S60 / S61
页数:2
相关论文
共 50 条
  • [1] Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
    Asa, Ehlen
    Brennan, Donal J.
    Alvarado-Kristensson, Maria
    Nodin, Bjorn
    O'Connor, Darran J.
    Uhler, Mathias
    Ponten, Fredrik
    Jirstrom, Karin
    [J]. CANCER RESEARCH, 2010, 70
  • [2] Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
    Åsa Ehlén
    Donal J Brennan
    Björn Nodin
    Darran P O'Connor
    Jakob Eberhard
    Maria Alvarado-Kristensson
    Ian B Jeffrey
    Jonas Manjer
    Jenny Brändstedt
    Mathias Uhlén
    Fredrik Pontén
    Karin Jirström
    [J]. Journal of Translational Medicine, 8
  • [3] Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
    Ehlen, Asa
    Brennan, Donal J.
    Nodin, Bjorn
    O'Connor, Darran P.
    Eberhard, Jakob
    Alvarado-Kristensson, Maria
    Jeffrey, Ian B.
    Manjer, Jonas
    Brandstedt, Jenny
    Uhlen, Mathias
    Ponten, Fredrik
    Jirstrom, Karin
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [4] High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
    Hjelm, Barbara
    Brennan, Donal J.
    Zendehrokh, Nooreldin
    Eberhard, Jakob
    Nodin, Bjorn
    Gaber, Alexander
    Ponten, Fredrik
    Johannesson, Henrik
    Smaragdi, Kristina
    Frantz, Christian
    Hober, Sophia
    Johnson, Louis B.
    Pahlman, Sven
    Jirstrom, Karin
    Uhlen, Mathias
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (11-12) : 624 - 635
  • [5] High nuclear expression of RBM3 is associated with an improved prognosis of clinical outcome in breast cancer
    Kwon, S. Y.
    Kang, S. H.
    Kang, Y. N.
    Choe, M.
    Hwang, I.
    Cho, J. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S117 - S117
  • [6] RBM3 expression loss is associated with right-sided localization and poor prognosis in colorectal cancer
    Marx, A. H.
    Simon, R.
    Lzbicki, J. R.
    Terracciano, L.
    Bokemeyer, C.
    Sauter, G.
    Melling, N.
    [J]. Oncology Research and Treatment, 2015, 38 : 60 - 60
  • [7] Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
    Jogi, Annika
    Brennan, Donal J.
    Ryden, Lisa
    Magnusson, Kristina
    Ferno, Marten
    Stal, Olle
    Borgquist, Signe
    Uhlen, Mathias
    Landberg, Goran
    Pahlman, Sven
    Ponten, Fredrik
    Jirstrom, Karin
    [J]. MODERN PATHOLOGY, 2009, 22 (12) : 1564 - 1574
  • [8] Decreased expression of RBM3 correlates with tumour progression and poor prognosis in urinary bladder cancer
    Boman, K.
    Ahlgren, G.
    Segersten, U.
    Eberhard, J.
    Ponten, F.
    Uhlen, M.
    Jirstrom, K.
    Malmstrom, P-U
    [J]. HISTOPATHOLOGY, 2012, 61 : 147 - 147
  • [9] Stress response protein RBM3 promotes the development of colitis-associated cancer
    Sakurai, Toshiharu
    Kudo, Masatoshi
    [J]. CANCER SCIENCE, 2018, 109 : 647 - 647
  • [10] Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer
    Sakurai, Toshiharu
    Kashida, Hiroshi
    Komeda, Yoriaki
    Nagai, Tomoyuki
    Hagiwara, Satoru
    Watanabe, Tomohiro
    Kitano, Masayuki
    Nishida, Naoshi
    Fujita, Jun
    Kudo, Masatoshi
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) : 66 - 74